Overview
- 9 inspections across 9 sites are on record.
- 39 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-06-25.
At a glance
Inspections
9
Sites
9
Observations
39
Career since
Nov 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Kedrion Biopharma Inc. | 25 Jun 2021 | Biologics | On file |
| Shandex Personal Care Manufacturing Inc. | 28 Nov 2014 | Human Drugs | View 483 → |
| Mondelez Canada Inc. | 21 Nov 2014 | Human Drugs | View 483 → |
| Activation Laboratories Ltd. | 14 Nov 2014 | Human Drugs | |
| Kabco Pharmaceuticals, Inc. | 12 Apr 2013 | Foods & Cosmetics | View 483 → |
Sites inspected
Kedrion Biopharma Inc.Melville, United States1 insp.
Shandex Personal Care Manufacturing Inc.Perth, Canada1 insp.
Mondelez Canada Inc.Scarborough, Canada1 insp.
Activation Laboratories Ltd.Ancaster, Canada1 insp.
Kabco Pharmaceuticals, Inc.Amityville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jessica L Pressley3 shared
Sarah A Meehan3 shared
Burnell M Henry1 shared
Susan M Jackson1 shared
Meredith P Soehl1 shared
Robert C Steyert1 shared
Uduak M Inokon1 shared
Alice S Tsao1 shared
Full investigator report
Get the verbatim findings behind Ann M Stewart's 39 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site